EMPULSE III期临床试验显示恩格列净能为急性心力衰竭住院后病情稳定的成人患者带来显著临床获益
EMPULSE III期临床试验显示恩格列净能为急性心力衰竭住院后病情稳定的成人患者带来显著临床获益
Region switcher
Use the region switcher to change your region and language preferences
返回
Change region and language
Search for a region
-
Global
-
Albania
-
Algeria
-
Argentina
-
Australia
-
Austria
-
Bahrain
-
Belarus
-
Belgium
-
Bosnia and Herzegovina
-
Botswana
-
Brazil
-
Bulgaria
-
Cambodia
-
Canada
-
Chile
-
Colombia
-
Croatia
-
Czech Republic
-
Denmark
-
Ecuador
-
Egypt
-
Estonia
-
Ethiopia
-
Finland
-
France
-
Germany
-
Ghana
-
Greece
-
Hong Kong (China)
-
Hungary
-
India
-
Indonesia
-
Iran
-
Ireland
-
Israel
-
Italy
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Latin America
-
Latvia
-
Lebanon
-
Libya
-
Lithuania
-
Mainland China
-
Malawi
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Middle East and North Africa
-
Moldova
-
Morocco
-
Namibia
-
Netherlands
-
New Zealand
-
Nigeria
-
Oman
-
Pakistan
-
Paraguay
-
Peru
-
Poland
-
Portugal
-
Qatar
-
Russia
-
Saudi Arabia
-
Serbia
-
Seychelles
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sub-Sahara Africa
-
Sudan
-
Sweden
-
Switzerland
-
Syria
-
Taiwan (China)
-
Tanzania
-
Thailand
-
Tunisia
-
Turkey
-
Uganda
-
Ukraine
-
United Arab Emirates
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Zimbabwe
Not what you are looking for?
Check out the global boehringer-ingelheim.com
请扫码关注我们
勃林格殷格翰官方
勃林格殷格翰HR
勃林格殷格翰动保